Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Australia Diagnostic Imaging Market Trends & Forecast 2025-2033" has been added to ResearchAndMarkets.com's offering.
The Australia Diagnostic Imaging Market is expected to reach US$ 1.16 billion by 2033 from US$ 733.95 million in 2024, with a CAGR of 5.22% from 2025 to 2033. Improvements in medical imaging technologies for precision, effectiveness, and safety of diagnostic procedures, rising need for early disease diagnosis, and the rising incidence of chronic disorders are driving the market's steady expansion. Another factor influencing Australia's diagnostic imaging market share is government programs that promote digital health and easier access to diagnostics.
Due to the provision of vital instruments for disease diagnosis, monitoring, and treatment planning, Australia's diagnostic imaging business is vital to the country's healthcare system. Nuclear medical imaging, CT scans, MRIs, ultrasounds, and X-rays are among the services provided by the business. It is fueled by a growing need for early diagnostic treatments, an aging population, and an increase in chronic diseases. Advances in technology, such as 3D visualization and AI-assisted imaging, are revolutionizing diagnostic capabilities, increasing accuracy, and improving patient outcomes. Imaging services are used by both the public and commercial healthcare systems, and many diagnostic procedures are significantly funded by Medicare.
In order to guarantee quality and safety, the Diagnostic Imaging Accreditation Scheme (DIAS) has established accreditation requirements for the highly regulated business. Alongside smaller independent providers, the market is dominated by large corporate companies like Capitol Health, Sonic Healthcare, and I-MED Radiology Network. While regional and rural areas continue to experience service shortages, urban centers usually have greater access to state-of-the-art imaging facilities. The Australian government has implemented measures to improve accessibility, such as tele-radiology and mobile imaging services, particularly for rural populations, in order to rectify this disparity.
The business has grown steadily in recent years, helped by increased government investment and healthcare spending. There are still issues, though, such as a lack of workers, especially sonographers and radiologists, and pressure to keep up with changing technological advancements. Furthermore, the industry's operational dynamics are changing due to the adoption of AI tools and digital health records, necessitating continued training and investment. Despite these obstacles, Australia's diagnostic imaging industry is expected to grow further due to robust demand, supportive legislation, and continuous innovation.
Key Factors Driving the Australia Diagnostic Imaging Market Growth
Growing Rate of Age-Related and Chronic Illnesses
The aging of the population and the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders are additional contributing factors to the growth of the diagnostic imaging market in Australia. These factors are greatly raising the need for diagnostic imaging in the country. In order to manage degenerative illnesses and comorbidities, elderly individuals usually need more regular imaging and monitoring. In oncology and cardiovascular care in particular, diagnostic imaging is essential for early detection, staging, and therapy planning. Health services are under pressure to offer fast and accurate diagnoses as life expectancy rises and lifestyle-related diseases become more common. Imaging services are crucial to Australia's healthcare policy and a major factor in the growth of imaging services since they are necessary for continuous disease treatment and preventive care.
For example, Body Vision Medical, a global leader in AI-powered intraoperative imaging, announced in March 2025 that their LungVision advanced imaging system had received approval from Australia's Therapeutic Goods Administration (TGA). With this approval, the company has achieved a significant milestone in its mission to increase early and accurate lung cancer diagnosis worldwide.
Government Support for Healthcare
In Australia, robust government assistance in the form of reimbursement schemes and subsidies is greatly expanding access to diagnostic imaging services. The nationwide public health program, Medicare, provides coverage for a wide range of imaging treatments, reducing patients' out-of-pocket expenses and encouraging prompt diagnosis. Additionally, funding supports bulk-billing procedures, guaranteeing that vulnerable populations, such as the elderly and those living in remote areas, have fair access to imaging technologies. The list of services that are eligible for reimbursement has been further expanded with the introduction of item numbers for more recent imaging techniques. Additionally, capital grants for modernizing digital infrastructure and radiology equipment improve operational effectiveness and service quality. These funding sources improve patient outcomes and stimulate demand and innovation in the diagnostic imaging industry in Australia.
Combining Precision Medicine with Integration
The integration of imaging technology with precision medicine is a significant trend that is revolutionizing the delivery of healthcare, per an analysis of the diagnostic imaging market in Australia. Diagnostic imaging gives critical data that informs tailored treatment plans, notably in domains such as oncology, cardiology, and neurology. Advanced imaging techniques, such as PET-CT and functional MRI, allow medical professionals to track treatment outcomes, identify disorders at the molecular level, and tailor interventions according to the biology of each patient. As the healthcare paradigm changes toward a more customized approach, imaging is increasingly utilized with genetic and laboratory data to influence clinical choices. This integration speeds up the adoption of AI and data analytics tools in medical imaging procedures, fosters cooperation between radiologists and specialists, and stimulates investment in state-of-the-art machinery.
Challenges in the Australia Diagnostic Imaging Market
The burden of regulations and compliance
The Diagnostic Imaging Accreditation Scheme (DIAS) is the main regulatory body that oversees the diagnostic imaging sector in Australia. Providers are guaranteed to adhere to strict safety, quality, and clinical efficacy criteria thanks to this framework. Despite being crucial for patient safety, these rules place a heavy administrative and financial strain on imaging centers. Maintaining compliance requires providers to update documentation, training procedures, and policies on a regular basis, which can put a strain on operational resources, especially for smaller or regional practices. Routine operations are further complicated by frequent audits and reporting requirements. For many diagnostic imaging services, maintaining compliance is a constant problem since rules change in tandem with clinical and technological developments, necessitating continuous investments in management systems, employee training, and quality assurance procedures.
Connecting Digital Health Systems
There are advantages and disadvantages to integrating diagnostic imaging services with Australia's national digital health systems, like My Health Record. Care coordination and patient outcomes are enhanced when imaging reports and scans can be shared easily between healthcare providers thanks to effective integration. However, a large investment in IT infrastructure, system updates, and interoperability solutions is needed to bring current imaging systems into line with emerging digital platforms. Technical obstacles affect many providers, particularly those who use out-of-date or incompatible software. Furthermore, considering the sensitive nature of medical imaging data, it is imperative to guarantee strong data security and privacy protection. Operational costs are increased by adherence to secure transmission protocols and cybersecurity regulations. Smaller suppliers with fewer financial and technical resources find these integration requirements particularly difficult to meet.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024-2033 |
| Estimated Market Value (USD) in 2024 | $733.95 Million |
| Forecasted Market Value (USD) by 2033 | $1.16 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Australia |
Key Topics Covered
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Australia Diagnostic Imaging Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Product
6.2 By Application
6.3 By End User
6.4 By States
7. Product
7.1 X-Ray
7.2 CT
7.3 Ultrasound
7.4 Nuclear Imaging
7.5 Others
8. Application
8.1 Orthopedics
8.2 Cardiovascular
8.3 Neurology
8.4 Pelvic & Abdomen
8.5 Oncology
9. End User
9.1 Hospital
9.2 Diagnostic Center
9.3 Others
10. Top States
10.1 New South Wales
10.2 Victoria
10.3 Queensland
10.4 Western Australia
10.5 South Australia
10.6 Australian Capital Territory
10.7 Tasmania
10.8 Northern Territory
11. Value Chain Analysis
12. Porter's Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Competition
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threats
14. Pricing Benchmark Analysis
14.1 FUJIFILM VisualSonics Inc.
14.2 Canon Medical Systems Corporation
14.3 Bruker Corporation
14.4 PerkinElmer Inc.
14.5 Hitachi
14.6 Hologic
14.7 Radnet
14.8 Koninklijke Philips
15. Key Players Analysis
15.1 FUJIFILM VisualSonics Inc.
15.2 Canon Medical Systems Corporation
15.3 Bruker Corporation
15.4 PerkinElmer Inc.
15.5 Hitachi
15.6 Hologic
15.7 Radnet
15.8 Koninklijke Philips
For more information about this report visit https://www.researchandmarkets.com/r/kuia5e
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
